Latest Breaking News On - Fuji pharma - Page 1 : comparemela.com

Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

11.06.2024 - Vistagen (Nasdaq: VTGN), a neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, .

United statesInternational number tollExchange commissionB developmentWomen health indicationsCompany phaseMental health america platinum bell sealFuji pharma co ltdAcute treatmentSocial anxiety disorderSubjective unitsDistress scaleMajor depressive disorderKey pherine mechanismPositive exploratory phaseData study

Alvotech stock gains on deals for J&J s Stelara (NASDAQ:ALVO)

Alvotech stock gains on deals for J&J s Stelara (NASDAQ:ALVO)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Pharma groupNational health insuranceSolution conceptsChalkboard backgroundFuji pharmaEuropean economic area

Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)

Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

South koreaNew zealandUnited statesUnited kingdomRepublic ofYangtze riverChina generalHong kongSaval latin americaRobert wessmanLotus pharmaceuticals co ltdTeva pharmaceutical industries ltdDrug administrationFuji pharma co ltd japanPharma groupFuji pharma co

Alvotech (ALVO) Announces Expected Global Market Entry Dates for AVT04

Alvotech (ALVO) Announces Expected Global Market Entry Dates for AVT04
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robert wessmanFuji pharma coDrug administrationPharma groupNational health insuranceEuropean economic areaEuropean supplementary protection certificateFuji pharmaBiologics license applicationBiosimilar user fee act

Alvotech settles with J&J to launch Stelara biosimilar in Europe, Canada

The deals allow Alvotech's biosimilar, or near copies of a biological drug, to enter the Canadian market in the first quarter of this year and Japan in May. Entry to the first European markets is expected after late July. Stelara has been J&J's top-selling drug since 2019, but its key patents began to expire last year.

United statesShilpi majumdarLeroy leoShounak dasguptaTeva pharmaceuticalFuji pharmaEuropean economicJohnson ampSettlement agreements